These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 23381952

  • 1. Quinolinesulfonamides of aryloxy-/arylthio-ethyl piperidines: influence of an arylether fragment on 5-HT1A/5-HT7 receptor selectivity.
    Grychowska K, Marciniec K, Canale V, Szymiec M, Glanowski G, Satała G, Maślankiewicz A, Pawłowski M, Bojarski AJ, Zajdel P.
    Arch Pharm (Weinheim); 2013 Mar; 346(3):180-8. PubMed ID: 23381952
    [Abstract] [Full Text] [Related]

  • 2. Arene- and quinoline-sulfonamides as novel 5-HT7 receptor ligands.
    Zajdel P, Marciniec K, Maślankiewicz A, Paluchowska MH, Satała G, Partyka A, Jastrzębska-Więsek M, Wróbel D, Wesołowska A, Duszyńska B, Bojarski AJ, Pawłowski M.
    Bioorg Med Chem; 2011 Nov 15; 19(22):6750-9. PubMed ID: 22001327
    [Abstract] [Full Text] [Related]

  • 3. Solid-Supported Synthesis and 5-HT7 /5-HT1A Receptor Affinity of Arylpiperazinylbutyl Derivatives of 4,5-dihydro-1,2,4-triazine-6-(1H)-one.
    Grychowska K, Masurier N, Verdié P, Satała G, Bojarski AJ, Martinez J, Pawłowski M, Subra G, Zajdel P.
    Chem Biol Drug Des; 2015 Oct 15; 86(4):697-703. PubMed ID: 25684690
    [Abstract] [Full Text] [Related]

  • 4. Quinoline- and isoquinoline-sulfonamide derivatives of LCAP as potent CNS multi-receptor-5-HT1A/5-HT2A/5-HT7 and D2/D3/D4-agents: the synthesis and pharmacological evaluation.
    Zajdel P, Marciniec K, Maślankiewicz A, Satała G, Duszyńska B, Bojarski AJ, Partyka A, Jastrzębska-Więsek M, Wróbel D, Wesołowska A, Pawłowski M.
    Bioorg Med Chem; 2012 Feb 15; 20(4):1545-56. PubMed ID: 22277589
    [Abstract] [Full Text] [Related]

  • 5. The impact of the halogen bonding on D2 and 5-HT1A/5-HT7 receptor activity of azinesulfonamides of 4-[(2-ethyl)piperidinyl-1-yl]phenylpiperazines with antipsychotic and antidepressant properties.
    Partyka A, Kurczab R, Canale V, Satała G, Marciniec K, Pasierb A, Jastrzębska-Więsek M, Pawłowski M, Wesołowska A, Bojarski AJ, Zajdel P.
    Bioorg Med Chem; 2017 Jul 15; 25(14):3638-3648. PubMed ID: 28529043
    [Abstract] [Full Text] [Related]

  • 6. N-Alkylated arylsulfonamides of (aryloxy)ethyl piperidines: 5-HT(7) receptor selectivity versus multireceptor profile.
    Canale V, Kurczab R, Partyka A, Satała G, Słoczyńska K, Kos T, Jastrzębska-Więsek M, Siwek A, Pękala E, Bojarski AJ, Wesołowska A, Popik P, Zajdel P.
    Bioorg Med Chem; 2016 Jan 15; 24(2):130-9. PubMed ID: 26706111
    [Abstract] [Full Text] [Related]

  • 7. Solid-supported synthesis, molecular modeling, and biological activity of long-chain arylpiperazine derivatives with cyclic amino acid amide fragments as 5-HT(7) and 5-HT(1A) receptor ligands.
    Canale V, Guzik P, Kurczab R, Verdie P, Satała G, Kubica B, Pawłowski M, Martinez J, Subra G, Bojarski AJ, Zajdel P.
    Eur J Med Chem; 2014 May 06; 78():10-22. PubMed ID: 24675176
    [Abstract] [Full Text] [Related]

  • 8. Parallel solid-phase synthesis and characterization of new sulfonamide and carboxamide proline derivatives as potential CNS agents.
    Zajdel P, Subra G, Bojarski AJ, Duszyńska B, Pawłowski M, Martinez J.
    Bioorg Med Chem; 2005 Apr 15; 13(8):3029-35. PubMed ID: 15781412
    [Abstract] [Full Text] [Related]

  • 9. New 1-arylindoles based serotonin 5-HT7 antagonists. Synthesis and binding evaluation studies.
    Sagnes C, Fournet G, Satala G, Bojarski AJ, Joseph B.
    Eur J Med Chem; 2014 Mar 21; 75():159-68. PubMed ID: 24531229
    [Abstract] [Full Text] [Related]

  • 10. Towards metabolically stable 5-HT7 receptor ligands: a study on 1-arylpiperazine derivatives and related isosters.
    Lacivita E, De Giorgio P, Patarnello D, Niso M, Colabufo NA, Berardi F, Perrone R, Satala G, Duszynska B, Bojarski AJ, Leopoldo M.
    Exp Brain Res; 2013 Oct 21; 230(4):569-82. PubMed ID: 23571499
    [Abstract] [Full Text] [Related]

  • 11. Sulfonamides with the N-alkyl-N'-dialkylguanidine moiety as 5-HT7 receptor ligands.
    Zajdel P, Subra G, Verdie P, Gabzdyl E, Bojarski AJ, Duszyńska B, Martinez J, Pawłowski M.
    Bioorg Med Chem Lett; 2009 Aug 15; 19(16):4827-31. PubMed ID: 19560916
    [Abstract] [Full Text] [Related]

  • 12. New N- and O-arylpiperazinylalkyl pyrimidines and 2-methylquinazolines derivatives as 5-HT7 and 5-HT1A receptor ligands: Synthesis, structure-activity relationships, and molecular modeling studies.
    Intagliata S, Modica MN, Pittalà V, Salerno L, Siracusa MA, Cagnotto A, Salmona M, Kurczab R, Romeo G.
    Bioorg Med Chem; 2017 Feb 01; 25(3):1250-1259. PubMed ID: 28063784
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7/5-HT1A receptor selectivity.
    Medina RA, Sallander J, Benhamú B, Porras E, Campillo M, Pardo L, López-Rodríguez ML.
    J Med Chem; 2009 Apr 23; 52(8):2384-92. PubMed ID: 19326916
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Novel derivatives of 2-pyridinemethylamine as selective, potent, and orally active agonists at 5-HT1A receptors.
    Vacher B, Bonnaud B, Funes P, Jubault N, Koek W, Assié MB, Cosi C, Kleven M.
    J Med Chem; 1999 May 06; 42(9):1648-60. PubMed ID: 10229633
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.